David H. Crean, Ph.D is a Managing Director at Objective Capital Partners, a middle market investment banking firm located in southern California, where he leads the firm’s Mergers and acquisitions (M&A), partnering, valuations and capital financing transactions with life science and healthcare companies. Dr. Crean has in excess of 25 years of life sciences R&D and corporate development transactional experience in the healthcare and biopharma industries. Dr. Crean holds FINRA Series 79 and Series 63 licenses and is a Registered Investment Banking Representative of BA Securities LLC, Member FINRA SIPC.
In parallel to his investment banking leadership, Dr. Crean serves in leading roles on the Boards of Directors for Histogen, Inc. (Nasdaq: HSTO) as Board Chairman and Chair of Audit, and he California Life Sciences Association (CLSA) as Chairman of Development and a member of the Executive Committee, as a business advisor for several life science companies, is a limited partner with Mesa Verde Venture Partners, and a member of Corporate Directors Forum. He is also a member of AdvisoryCloud, Boardsi and a contributing author for Forbes.com through his work with Forbes Los Angeles Business Council. For his outstanding advisory work, Dr. Crean was recognized by San Diego Business Journal for SD500 Most Influential Business Leaders in 2020, M&A Advisors for the 2019 Investment Banker of the Year, San Diego Business Journal’s 2018 Healthcare Hero, 2017 Thought Leader of the Year and 2017 Advisor of the Year Awards. Dr. Crean is also active in the non-profit sector where he serves in leading Board of Director roles for the Association for Corporate Growth (ACG) San Diego as President, and as Chairman of the Alzheimer’s Association of San Diego/ Imperial Counties and Student Success Programs of the Charter School of San Diego.
In parallel to his investment banking leadership, Dr. Crean serves in leading roles on the Boards of Directors for Histogen, Inc. (Nasdaq: HSTO) as Board Chairman and Chair of Audit, and he California Life Sciences Association (CLSA) as Chairman of Development and a member of the Executive Committee, as a business advisor for several life science companies, is a limited partner with Mesa Verde Venture Partners, and a member of Corporate Directors Forum. He is also a member of AdvisoryCloud, Boardsi and a contributing author for Forbes.com through his work with Forbes Los Angeles Business Council. For his outstanding advisory work, Dr. Crean was recognized by San Diego Business Journal for SD500 Most Influential Business Leaders in 2020, M&A Advisors for the 2019 Investment Banker of the Year, San Diego Business Journal’s 2018 Healthcare Hero, 2017 Thought Leader of the Year and 2017 Advisor of the Year Awards. Dr. Crean is also active in the non-profit sector where he serves in leading Board of Director roles for the Association for Corporate Growth (ACG) San Diego as President, and as Chairman of the Alzheimer’s Association of San Diego/ Imperial Counties and Student Success Programs of the Charter School of San Diego.
Speaking In
11:00 AM - 12:00 PM (PDT)
Tuesday, October 13
More than half of biotech CEOs are first-time CEOs, but even the most experienced leadership teams…
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
